ZP9830: New Medication Study

We are testing different doses of ZP9830 in healthy volunteers to see how it affects the body. This research helps us find safe dosage levels for future treatments.

1-2 yearsSafety phase (I)Internal Medicine

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Centre for Human Drug Research
Immunology
Oegstgeest, Netherlands
Sponsor: Zealand Pharma A/S
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.